Compare MC & TFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MC | TFX |
|---|---|---|
| Founded | 2007 | 1943 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.9B | 5.8B |
| IPO Year | 2014 | 1994 |
| Metric | MC | TFX |
|---|---|---|
| Price | $67.85 | $134.74 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 8 |
| Target Price | $72.88 | ★ $138.75 |
| AVG Volume (30 Days) | ★ 891.6K | 390.5K |
| Earning Date | 04-29-2026 | 05-07-2026 |
| Dividend Yield | ★ 3.88% | 1.02% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.75 | N/A |
| Revenue | N/A | ★ $1,992,713,000.00 |
| Revenue This Year | $18.28 | $15.97 |
| Revenue Next Year | $17.22 | $5.15 |
| P/E Ratio | $89.39 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $51.06 | $100.18 |
| 52 Week High | $78.22 | $139.67 |
| Indicator | MC | TFX |
|---|---|---|
| Relative Strength Index (RSI) | 52.00 | 55.58 |
| Support Level | $61.71 | $126.25 |
| Resistance Level | $72.13 | $136.86 |
| Average True Range (ATR) | 2.55 | 4.18 |
| MACD | 0.13 | 0.24 |
| Stochastic Oscillator | 52.12 | 61.09 |
Moelis & Co is an independent investment bank that provides strategic and financial advice to a diverse client base, including corporations, financial sponsors, governments, and sovereign wealth funds. The company assists its clients in achieving their strategic goals by offering comprehensive, globally integrated financial advisory services across all industry sectors. It also advises clients on their critical decisions, including mergers and acquisitions, recapitalizations and restructurings, capital markets transactions, and other corporate finance matters. It generates revenue from advisory transactions. The firm derives a majority of its revenue from the United States, followed by Europe and the rest of the World.
Teleflex Inc is a provider of medical technology products focused on enhancing clinical benefits, improving patient and provider safety and reducing total procedural costs. It designs, develops, manufactures and supply medical devices used by hospitals and healthcare providers supporting high-acuity emergent procedures. The company has three reportable segments: Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). It derives maximum revenue from Americas. Its products includes: Anaesthesia, Emergency Medicine, Interventional Cardiology/Radiology, Interventional Urology - UroLift System, Surgery, Urology, and Vascular Access.